Antidepressant-like action of diacamphe against the background stress-induced behavioral depression

封面

如何引用文章

详细

Background. It was find out the cerebroprotective properties of diacamphe – (±)-cis-3-(2’-benzimidazolyl)-1,2,2-trimethylcyclopentan-carbonic acid hydrochloride in vivo experiments in the some models of brain injury.

Aim. To investigate the neuroprotective and antidepressant-like activities of diacamphe.

Materials and Methods. It was investigated an impact of diacamphe on inhibition of the pyramidal neurons field synaptic potentials evoked by N-methyl-D-aspartate, procedure anoxia/neuroaglicemia, and H2O2 in the electrophysiological experiments on hippocampal slices for evaluating of diacamphe neuroprotective activity. It was explored in behavioral experiments the impacts of diacamphe and antidepressant imipramine on basic manifestations of behavioral depression evoked by five-days swimming stress – helplessness and anhedonia.

Results. It was ascertained in experiments on the hippocampal slices that diacamphe especially at conditions of systemic administration diminished of injury of the pyramidal neurons synapses induced by procedure anoxya/aglicemia, oxidative stress, but not N-methyl-D-aspartate action. The chronic administration of diacamphe in dose 10 mg/kg reduced the manifestations of induced by swimming stress behavioral depression, decrease duration of immobility in forced swimming test (helplessness) and increase preference of intake of sweet solution comparably with water (dilution of anhedonia). Antidepressant-like action of diacamphe differences from action of traditional antidepressant imipramine so far as diacamphe did not diminishes immobilization duration in swimming test after single administration and by more slow developing of action.

Conclusions. Diacamphe possesses neuroprotective action and therefore manifests antidepressant-like action against the background behavioral depression evoked by swimming stress.

作者简介

Tamara Zayka

M. Gorkiy Donetsk National Medical University

Email: abrametz2009@yandex.ru
ORCID iD: 0000-0003-0950-5999
SPIN 代码: 8344-1556
Researcher ID: D-1558-2018

Assistant of Department of Pharmacology and Clinical Pharmacology

乌克兰, Donetsk, DPR

Dmitriy Evdokimov

M. Gorkiy Donetsk National Medical University

Email: abrametz2009@yandex.ru
ORCID iD: 0000-0003-2989-7811
SPIN 代码: 2998-0084
Researcher ID: D-5538-2018

MD, PhD, Associate Professor of Department of Pharmacology and Clinical Pharmacology

乌克兰, Donetsk, DPR

Igor Abramets

M. Gorkiy Donetsk National Medical University

编辑信件的主要联系方式.
Email: abrametz2009@yandex.ru
ORCID iD: 0000-0002-2229-7541
SPIN 代码: 9831-1762
Researcher ID: C-9940-2018

MD, Grand PhD, Professor of Department of Pharmacology and Clinical Pharmacology

乌克兰, Donetsk, DPR

参考

  1. Shatilova OA. Eksperimental'noe izuchenie cerebro-protectivnykh i psikhotropnykh svoystv diakamfa [disserta-tion]. Khar’kov; 2010. (In Russ).
  2. Shvedsky VV, Shtrygol SYu, Merzlikin SI. Vplyv diakamfu gidrokhlorydu na pokaznyky energe-tychnogo obminu v golovnomu mozku shchuriv iz modellyu cerebral'noi ishemii na tli cukrovogo diabetu. Clinichna Pharmaciya. 2011;15(3):57-61. (In Ukrainian).
  3. Shvedskiy VV, Shtrygol SYu, Merzlikin SI, et al. Vplyv diakamfu gidrokhlorydu na intensyvnist neyroapoptozu pry eksperimentalnomu porushenni mozkovogo krovoobigu na tli cukrovogo. Pharmacologiya i Medicinskaya Toxicologiya. 2012;2:49-53. (In Ukrainian).
  4. Shvedskiy VV. Vplyv diakamfu gidrokhlorydu na krovopostachannya golovnogo mozku za ishemii-reperfuzii na tli alloksanovogo cukrovogo diabetu u shchuriv. Ukrains’kiy biopharmacevtychniy zhurnal. 2012;1-2:18-21. (In Ukrainian).
  5. Abramets II, Evdokimov DV, Talalayenko AN. Vliyanie chronicheskogo vvedeniya antidepressantov na pov-rezhdenie neyronov hippokampa i kory, vysyvaemoe vvedeniem NMDA (N-methyl-Daspar-tate. Neurophysi-ology. 2010;42(1):20-7. (In Russ).
  6. Abramets II, Evdokimov DV, Talalayenko AN. Rannie anoksicheskie povrezhdeniya hippokampa i ikh iz-meneniya obuslovlennye khronicheskim deystviem antidepressantov. Neurophysiology. 2011;43(2):123-33. (In Russ).
  7. Yacenko KA, Glazova NY, Inozemtseva LS, et al. Geptapeptid Semaks oslablyaet posledstviya nepredskazue-mogo khronicheskogo stressa u krys. Doklady Academii Nauk. 2013;453(5):581-4. (In Russ).
  8. Nussbaumer M, Asara JM, Teplitska A, et al. Selective mitochondrial targeting exerts anxiolytic effects in vivo. Neuropsychopharmacology. 2016; 41(7):1751-8.
  9. Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsy-chopharmacology. 2008;33(12):2080-92.
  10. Abramets II, Evdokimov DV, Talalayenko AN, et al. Central'naya glutamatergicheskaya sinapti-cheskaya peredacha pri povedencheskoy depressii u krys. Neyronauki: theoretichni ta clinichni aspecty. 2006;2(1-2):22-30. (In Russ).
  11. Liu Y, Wong TP, Aarts M, et al. NMDA receptor subunits have differential roles in mediating exitotoxic neuronal death in vitro and in vivo. Journal of Neuroscience. 2007;27(11):2846-57.
  12. Tian GF, Baker AJ. Protective effect of high glucose against ischemia-induced synaptic transmission damage in rat hippocampal slices. Journal of Neurophysiology. 2002;88(2):236-48.
  13. De Almeida L, Leite MC, Tomazi AP, et al. M. Rosveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats. Archive of Biochemistry and Biophysics. 2008;480(1):27-32.
  14. Porsolt RD, Bertin A, Jalfre M. Behavioural «despair» in rats and mice: strain differences and the ef-fects of imipramine. European Journal of Pharmacology. 1978;51(3):291-4.
  15. Benelli A, Filaferro M, Bertolini A, et al. Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats. British Journal of Pharmacology. 1999;127(3):645-54.
  16. Sun P, Wang F, Wang L, et al. Increase in cortical pyramidal cell excitability accompanies depression-like behav-ior in mice: a transcranial magnetic stimulation study. Journal of Neuroscience. 2011; 31(45):16464-72.
  17. Sachdev PS, McBride R, Loo C, et al. Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats. Biological Psychiatry. 2002; 51(3):474-9.
  18. Mul JD, Zheng J, Goodyear LJ. Validity assessment of 5 day repeated forced-swim to model human depression in young-adult C57BL/6J and BALB/cJ mice. eNeuro. 2016;3(6):ENEURO.0201 -16.2016. doi: 10.1523/ENEURO.0201-16.2016
  19. Serchov T., Clement HW, Schwarz MK, et al. Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depression-like behavior via induction of Homer1a. Neuron. 2015:87(2):549-62. doi: 10.1016/j.neuron.2015.07.010

补充文件

附件文件
动作
1. JATS XML

版权所有 © Zayka T.O., Evdokimov D.V., Abramets I.I., 2018

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
 


##common.cookie##